Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Azithromycin

Known as: Azithromycin [Chemical/Ingredient], N-methyl-11-aza-10-deoxy-10-dihydroerythromycin A, Azithromycine 
An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract Background Chloroquine and hydroxychloroquine have… Expand
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2020
Highly Cited
2020
Importance In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Highly Cited
2020
Highly Cited
2020
Importance Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2020
Highly Cited
2020
Abstract Background Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19… Expand
  • table 1
  • figure 1
  • figure 2
Highly Cited
2012
Highly Cited
2012
BACKGROUND Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2011
Highly Cited
2011
BACKGROUND Acute exacerbations adversely affect patients with chronic obstructive pulmonary disease (COPD). Macrolide antibiotics… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2003
Highly Cited
2003
CONTEXT Treatment strategies for cystic fibrosis (CF) lung disease include antibiotics, mucolytics, and anti-inflammatory… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2002
Highly Cited
2002
BACKGROUND The macrolide antibiotic azithromycin has anti-inflammatory properties potentially beneficial in cystic fibrosis… Expand
Highly Cited
2001
Highly Cited
2001
ABSTRACT We report that 2 μg of azithromycin/ml inhibits the quorum-sensing circuitry of Pseudomonas aeruginosa strain PAO1… Expand
Highly Cited
1990
Highly Cited
1990
The pharmacokinetics of azithromycin, a new azalide antibiotic, were examined in man. Approximately 37% of a single oral dose of… Expand